PATENT CLAIM ANALYSIS

Application Number: 16247497
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-06
Patent Classification: ["514", "398000"]

Abstract:
The present disclosure provides mucoadhesive aqueous-based gel formulations of metronidazole useful for a variety of purposes including intravaginal application as a therapeutic approach towards the treatment of individuals suffering from and/or diagnosed with bacterial vaginosis.

Claim (Index 11):
The method of  claim 1  wherein the subject is not Amsel positive within 5 days after administration.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 99.0
- Lexical Diversity: 1.09091
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14921737', '13593386', '13536960', '10946133', '14311200']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7813852327201454
- 35 USC 102 Novelty (BERT): 0.5835673335132412
- Combined Prediction Score: 0.7616034427994549
- Mean Citation Score: 392.823974
- Max Citation Score: 544.3213
- Similarity Product: 360.1442844129741

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test